Aggressive retinal hemangioblastoma with scleral penetration in Von-Hippel-Lindau syndrome

2021 ◽  
Vol 1 (4) ◽  
pp. 742
Author(s):  
Ferzana Mohammed ◽  
Sandya Somasundaran ◽  
Jyothi Poothatta ◽  
Suma Unnikrishnan
1984 ◽  
Vol 60 (6) ◽  
pp. 1279-1281 ◽  
Author(s):  
Sezgin Mehmet Ismail ◽  
Gillian Cole

✓ The authors describe a case of von Hippel-Lindau syndrome diagnosed at autopsy in a 49-year-old woman. She died suddenly following hemorrhage from a cerebellar hemangioblastoma. Other autopsy findings included a retinal hemangioblastoma, an adrenal pheochromocytoma, and a clear-cell renal tumor. The case was distinguished by the unexpected finding of multiple microscopic hemangioblastomas of the spinal nerve roots. The case is discussed with emphasis on the incidence of spinal hemangioblastomas in von Hippel-Lindau syndrome.


2017 ◽  
Author(s):  
Moreira Ana Paula ◽  
Gracinda Costa ◽  
de Lima Joao Pedroso

Author(s):  
Samantha E. Greenberg ◽  
Luke D. Maese ◽  
Benjamin L. Maughan

2021 ◽  
Vol 16 (8) ◽  
Author(s):  
Helen Ng ◽  
Vinson Wai-Shun Chan ◽  
Jon Cartledge ◽  
Michael Kimuli ◽  
Christy Ralph ◽  
...  

2021 ◽  
pp. 1-10
Author(s):  
Hashim Ali Khan ◽  
Muhammad Aamir Shahzad ◽  
Fatima Iqbal ◽  
Muhammad Amer Awan ◽  
Qaim Ali Khan ◽  
...  

Author(s):  
F. Scolari ◽  
B.F. Viola ◽  
L. Grazioli ◽  
R. Maiorca

2021 ◽  
Vol 79 ◽  
pp. S295
Author(s):  
R. Giles ◽  
K. Dreijerink ◽  
R.S. Van Leeuwaarde ◽  
A.N. Van Der Horst-Schrivers ◽  
T.P. Links

2021 ◽  
Vol 14 (8) ◽  
pp. e244077
Author(s):  
Ahmed Adan ◽  
Luke Carine ◽  
Heinrich Heimann ◽  
Marta Ugarte

A 71-year-old Caucasian man presented with an isolated juxtapapillary retinal capillary haemangioblastoma on the superior and temporal left optic disc with active exudation resulting in macular intraretinal and subretinal fluid, reduced vision, scotoma and distortion with progression over 6 weeks. He did not have von Hippel-Lindau syndrome. After proton beam radiotherapy (PBR), the tumour size remained unchanged, but did not stop the exudation. Three anti-vascular endothelial growth factor (VEGF) (ie, bevacizumab) injections at monthly intervals resulted in reduced macular oedema. Combined therapy with PBR and anti-VEGF injections sustained our patient’s vision at 12 months follow-up.


Sign in / Sign up

Export Citation Format

Share Document